The below online CPD modules from the current edition of Australian Pharmacist are available free for PSA members.
October 2020 – Chronic disease management
Treatment for blood cancers have gone through remarkable advances in the last decades with greater understanding of molecular pathology, targeted therapies, immunotherapies and other technologies. As a result, there has been a progressive increase in survival rates in patients diagnosed with blood cancers. Pharmacists in the community are increasingly likely to assist patients with chronic myeloid leukaemia (CML) and chronic lymphocytic leukaemia (CLL) as oral targeted medicines play a critical role in therapy. This article will discuss CML.
October 2020 – Disease management
Angina is a common condition, with an estimated 230 000 Australians being affected. Management of angina involves treating and preventing episodes of angina as well as secondary prevention of cardiovascular events. Pharmacists have a key role in ensuring safe use of medicines, educating patients on angina management and risk of cardiovascular events.
October 2020 – Over the counter
Otitis media is a very common infection of the middle ear, mainly affecting young children under the age of 6 and is often self-limiting. Pharmacists are well placed to help identify otitis media and assist in its management, as well as playing a key role in referral for cases requiring pharmacological treatment.
October 2020 – Clinical sponsored
Conventional synthetic disease-modifying anti-rheumatic drugs (csDMARDs) and, more recently, biological and targeted synthetic DMARDs (bDMARDs and tsDMARDs) have enhanced management outcomes for patients with diseases such as rheumatoid arthritis (RA), psoriatic arthritis (PsA) and ankylosing spondylitis (AS).
PSA members can view articles and submit answers to assessment questions from Australian Pharmacist CPD from the previous 24 months by clicking the links below.